BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22031643)

  • 1. Pustular pyoderma gangrenosum.
    Leger M; Newlove T; Chu J; Meehan S; Stein J
    Dermatol Online J; 2011 Oct; 17(10):17. PubMed ID: 22031643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetrical, painful ulceration of the lower limbs in a vascular surgery ward: a diagnostic challenge. Pyoderma gangrenosum associated with IgG-kappa paraproteinaemia.
    Simsek S; van den Haak RF; Voskuyl AE; Rauwerda JA; Strack van Schijndel RJ
    Neth J Med; 2004 May; 62(5):168-71. PubMed ID: 15366702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum complicating pacemaker implant.
    Cosío FG; Herrada CG; Monereo A; Pastor A; Núñez A
    Europace; 2006 Dec; 8(12):1068-9. PubMed ID: 17098783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
    Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.
    Schmid MH; Hary C; Marstaller B; Konz B; Wendtner CM
    Eur J Dermatol; 1998; 8(1):45-7. PubMed ID: 9649713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum in an infant.
    Torrelo A; Colmenero I; Serrano C; Vilanova A; Naranjo R; Zambrano A
    Pediatr Dermatol; 2006; 23(4):338-41. PubMed ID: 16918628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
    Carrasco Cubero C; Ruiz Tudela MM; Salaberri Maestrojuan JJ; Pérez Venegas JJ
    Reumatol Clin; 2012; 8(2):90-2. PubMed ID: 22104047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma.
    Ahmad K; Ramsay B
    Clin Exp Dermatol; 2009 Jan; 34(1):46-8. PubMed ID: 18627386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.
    Jones RR; Kobza Black A; Donaghy M; Moshtael O; Pinching AJ
    Clin Exp Immunol; 1983 Jun; 52(3):685-92. PubMed ID: 6409473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.
    de Zwaan SE; Iland HJ; Damian DL
    Australas J Dermatol; 2009 Feb; 50(1):56-9. PubMed ID: 19178495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum.
    Shareef MS; Munro LR; Owen RG; Highet AS
    Clin Exp Dermatol; 2012 Mar; 37(2):146-8. PubMed ID: 22103549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcorneal pustulosis and Pyoderma gangrenosum associated with a biclonal gammopathy.
    Puechguiral-Renaud I; Carpentier O; Piette F; Delaporte E
    Eur J Dermatol; 2006; 16(6):687-90. PubMed ID: 17229613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
    Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
    Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vegetative pyoderma gangrenosum.
    Kim RH; Lewin J; Hale CS; Meehan SA; Stein J; Ramachandran S
    Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pyoderma gangrenosum. 15 cases].
    Riahi I; Mokni M; Haouet S; Cherif F; El Euch D; Azaiz MI; Zitouna MM; Ben Osman-Dhahri A
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy.
    Mijuşković ZP; Zecević RD; Pavlović MD
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):697-9. PubMed ID: 15482299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome.
    Chiang M; Fleming M
    Am J Dermatopathol; 2007 Jun; 29(3):293-5. PubMed ID: 17519630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
    Velasco-Tamariz V; Carreño-Tarragona G; Tous-Romero F; Gil-de la Cruz E; Martín-Clavero E; Rivera-Díaz R
    Int Wound J; 2017 Dec; 14(6):1382-1384. PubMed ID: 28371346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum following an orthopedic surgical procedure.
    de Thomasson E; Caux I
    Orthop Traumatol Surg Res; 2010 Sep; 96(5):600-2. PubMed ID: 21411042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.